71
Participants
Start Date
March 6, 2023
Primary Completion Date
November 8, 2023
Study Completion Date
January 29, 2024
TDM-105795, 0.0025%
The assigned drug will be applied once daily for 16 weeks, with application to the scalp focusing on the regions that are bald and thinning.
TDM-105795, 0.02%
The assigned drug will be applied once daily for 16 weeks, with application to the scalp focusing on the regions that are bald and thinning.
TDM-105795 topical vehicle solution
The assigned placebo will be applied once daily for 16 weeks, with application to the scalp focusing on the regions that are bald and thinning.
Site 2, Norfolk
Site 8, Murfreesboro
Site 5, Knoxville
Site 7, Plainfield
Site 9, New Brighton
Site 10, Minneapolis
Site 4, Rolling Meadows
Site 13, New Orleans
Site 11, Baton Rouge
Site 12, North Little Rock
Site 6, College Station
Site 1, Austin
Site 3, Portland
Therapeutics, Inc.
INDUSTRY
Technoderma Medicines Inc.
INDUSTRY